HIGHLIGHTS
- who: Alexis Laurent et al. from the Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, Epalinges, Switzerland have published the article: Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care, in the Journal: Pharmaceutics 2023, 184 of 16/Nov/2023
- what: To set the appropriate general context the first aim of this study was to provide a current global overview of approved cell and gene therapy products with an emphasis cytotherapies for cutaneous application. This study shows the strong current interest in biological-based . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.